RxDoctor Payments Data
★ My doctorsLook up a doctor →

Clyde Jones

Hematology & Oncology · Memphis, TNNPI 1477557064

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,600 of the $54,112 with a category attached, or 67.6%. E.r. Squibb & Sons, L.L.C. accounts for 85.9% of it on its own, with 52 other manufacturers making up the rest. Reporting peaked in 2019 at $29,380 and has fallen 99.9% since, to $19 in 2024.

$54,112in general payments, 2019–2025

Across 461 payments — averaging $117.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$47K
  • Bristol Myers Squibb$1K
  • AstraZeneca$627
  • GSK$616
  • Novartis$402
  • Johnson & Johnson$378
  • plus $4K from 47 others
$52,253in research payments, 2019–2025

Across 24 payments — averaging $2177.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$16K
  • Pfizer$13K
  • E.r. Squibb & Sons, L.L.C.$7K
  • Apellis Pharmaceuticals, Inc.$5K
  • Incyte Corporation$5K
  • Shire North American Group Inc$4K
  • plus $3K from 2 others

What the payments were for

  • Consulting fees$7,25013%
  • Speaking & faculty fees$36,60068%
  • Travel & lodging$2,6695%
  • Food & beverage$7,43314%
  • Education$1600%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.96$46,504
Bristol Myers Squibb20$1,177
AstraZeneca18$627
GSK11$616
Novartis28$402
Johnson & Johnson(2 entities)30$378
Merck23$372
Amgen18$314
Eisai Inc.15$278
Lilly USA, LLC15$265
Seagen Inc.15$227
Pfizer18$222
Daiichi Sankyo Inc.11$206
Astellas Pharma US Inc7$181
AbbVie10$155
Exelixis Inc.12$151
Gilead(2 entities)8$149
Incyte Corporation8$139
Beigene USA, Inc.8$135
Puma Biotechnology, Inc.8$132
Takeda Pharmaceuticals U.S.A., Inc.6$126
Rigel Pharmaceuticals, Inc.5$117
Agios Pharmaceuticals, Inc.7$110
Pharmacyclics LLC, An Abbvie Company7$104
Taiho Oncology, Inc.3$100
Genentech USA, Inc.6$94
Sanofi5$87
Kyowa Kirin, Inc.4$65
Acrotech Biopharma Inc.3$55
Secura Bio, Inc.2$49
Servier Pharmaceuticals LLC3$48
Tesaro, Inc.2$47
Deciphera Pharmaceuticals Inc.2$47
Acceleron Pharma, Inc.2$38
Regeneron Healthcare Solutions, Inc.2$37
Clovis Oncology, Inc.3$34
Bayer2$31
Verastem, Inc.2$28
AMAG Pharmaceuticals, Inc.2$22
Biocompatibles, Inc.1$22
EMD Serono, Inc.1$22
ADC Therapeutics America, Inc.1$21
Sobi, Inc1$20
Boston Scientific1$19
Ipsen Biopharmaceuticals, Inc1$18
AVEO Pharmaceuticals, Inc.1$18
Pharmacosmos Therapeutics Inc.1$18
Stemline Therapeutics Inc.1$17
CTI Biopharma Corp.1$17
Emmaus Medical, Inc.1$15
Array Biopharma Inc1$15
Foundation Medicine, Inc.1$12
Teva Pharmaceuticals USA, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,112 in reported general payments places this provider in the 80th percentile of 251 hematology & oncology providers in Tennessee.

See all hematology & oncology providers in Tennessee →

Other hematology & oncology in Memphis

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →